Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma

The syndrome of Leser‐Trélat (LT) is a rare paraneoplastic syndrome. However, patients presenting with the sign of Leser‐Trélat should be considered to harbor an occult malignancy or a progressive tumor disease until “proven” otherwise. Herein, we present two cases of non‐small‐cell lung carcinoma a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khemakhem, Rim, Kallel, Nesrine, Jarraya, Rahma, Yangui, Ilhem, Kammoun, Samy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347334/
https://www.ncbi.nlm.nih.gov/pubmed/35937026
http://dx.doi.org/10.1002/ccr3.6069
_version_ 1784761840779132928
author Khemakhem, Rim
Kallel, Nesrine
Jarraya, Rahma
Yangui, Ilhem
Kammoun, Samy
author_facet Khemakhem, Rim
Kallel, Nesrine
Jarraya, Rahma
Yangui, Ilhem
Kammoun, Samy
author_sort Khemakhem, Rim
collection PubMed
description The syndrome of Leser‐Trélat (LT) is a rare paraneoplastic syndrome. However, patients presenting with the sign of Leser‐Trélat should be considered to harbor an occult malignancy or a progressive tumor disease until “proven” otherwise. Herein, we present two cases of non‐small‐cell lung carcinoma associated with LT syndrome.
format Online
Article
Text
id pubmed-9347334
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93473342022-08-05 Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma Khemakhem, Rim Kallel, Nesrine Jarraya, Rahma Yangui, Ilhem Kammoun, Samy Clin Case Rep Case Report The syndrome of Leser‐Trélat (LT) is a rare paraneoplastic syndrome. However, patients presenting with the sign of Leser‐Trélat should be considered to harbor an occult malignancy or a progressive tumor disease until “proven” otherwise. Herein, we present two cases of non‐small‐cell lung carcinoma associated with LT syndrome. John Wiley and Sons Inc. 2022-08-03 /pmc/articles/PMC9347334/ /pubmed/35937026 http://dx.doi.org/10.1002/ccr3.6069 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Khemakhem, Rim
Kallel, Nesrine
Jarraya, Rahma
Yangui, Ilhem
Kammoun, Samy
Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
title Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
title_full Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
title_fullStr Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
title_full_unstemmed Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
title_short Leser‐Trélat syndrome secondary to non‐small‐cell lung carcinoma
title_sort leser‐trélat syndrome secondary to non‐small‐cell lung carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347334/
https://www.ncbi.nlm.nih.gov/pubmed/35937026
http://dx.doi.org/10.1002/ccr3.6069
work_keys_str_mv AT khemakhemrim lesertrelatsyndromesecondarytononsmallcelllungcarcinoma
AT kallelnesrine lesertrelatsyndromesecondarytononsmallcelllungcarcinoma
AT jarrayarahma lesertrelatsyndromesecondarytononsmallcelllungcarcinoma
AT yanguiilhem lesertrelatsyndromesecondarytononsmallcelllungcarcinoma
AT kammounsamy lesertrelatsyndromesecondarytononsmallcelllungcarcinoma

Ejemplares similares